Oral Cladribine in Patients who Change From First-Line Disease Modifying Treatments for Multiple Sclerosis: Protocol of a Prospective Effectiveness and Safety Study (CLAD CROSS)

Authors
Category Primary study
JournalJournal of Central Nervous System Disease
Year 2022
This article has no abstract
Epistemonikos ID: 5a902bbb285df1091c73fb86d8b88a18c06eade2
First added on: Feb 14, 2025